Insulins
Insulin Glargine
Insulin glargine is a long-acting basal insulin analog providing a stable, ~24-hour glucose-lowering profile from a single daily injection. BOOKPHARM supplies insulin glargine as a biosimilar drug substance and supports prefilled-pen finished dosage.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFInsulins | License-out/Supply | NMPA approval |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.